IL2 and colorectal carcinoma: The result of PBMCs from CRC patients showed that cell cytotoxicity in the PBMC+IL2 (p < 0.001), PBMC+PC (p < 0.01) and PBMC+G2 (p < 0.05) groups was significantly higher than in the PBMC group.